BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
21 results:

  • 1. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
    Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell leukemia.
    Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Donor KIR2DS1-Mediated Decreased Relapse and Improved Survival Depending on Remission Status at HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
    Ido K; Koh H; Hirose A; Okamura H; Koh S; Nanno S; Nishimoto M; Nakamae M; Nakashima Y; Nakane T; Hino M; Nakamae H
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):723-733. PubMed ID: 31899360
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
    Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
    Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
    Kuželová K; Brodská B; Schetelig J; Röllig C; Ráčil Z; Walz JS; Helbig G; Fuchs O; Vraná M; Pecherková P; Šálek C; Mayer J
    PLoS One; 2018; 13(12):e0204290. PubMed ID: 30557403
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic alterations in adult T-cell leukemia/lymphoma.
    Kogure Y; Kataoka K
    Cancer Sci; 2017 Sep; 108(9):1719-1725. PubMed ID: 28627735
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.
    Tie R; Zhang T; Yang B; Fu H; Han B; Yu J; Tan Y; Huang H
    Oncotarget; 2017 Apr; 8(16):27645-27660. PubMed ID: 28206973
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BCR-ABL-specific CD4
    Ueda N; Zhang R; Tatsumi M; Liu TY; Kitayama S; Yasui Y; Sugai S; Iwama T; Senju S; Okada S; Nakatsura T; Kuzushima K; Kiyoi H; Naoe T; Kaneko S; Uemura Y
    Cell Mol Immunol; 2018 Jan; 15(1):15-26. PubMed ID: 27181332
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in Children.
    Sawada A; Inoue M; Kondo O; Yamada-Nakata K; Ishihara T; Kuwae Y; Nishikawa M; Ammori Y; Tsuboi A; Oji Y; Koyama-Sato M; Oka Y; Yasui M; Sugiyama H; Kawa K
    Pediatr Blood Cancer; 2016 Feb; 63(2):234-41. PubMed ID: 26469989
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
    Miyazaki Y; Fujiwara H; Asai H; Ochi F; Ochi T; Azuma T; Ishida T; Okamoto S; Mineno J; Kuzushima K; Shiku H; Yasukawa M
    Blood; 2013 Jun; 121(24):4894-901. PubMed ID: 23641014
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
    He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.
    Nunes CT; Miners KL; Dolton G; Pepper C; Fegan C; Mason MD; Man S
    Cancer Res; 2011 Aug; 71(16):5435-44. PubMed ID: 21697278
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.
    Yong AS; Stephens N; Weber G; Li Y; Savani BN; Eniafe R; Keyvanfar K; Kurlander R; Rezvani K; Barrett AJ
    Leukemia; 2011 Apr; 25(4):629-37. PubMed ID: 21252986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
    Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
    Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A clinical study of 31 patients with malignant hematopoietic disease treated with non-T cell-depleted HLA-haploidentical hematopoietic stem cell transplantation].
    Yang MZ; Yuan YH; Wu DP; Chang WR; He J; Di WY
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):482-5. PubMed ID: 17663825
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
    Ait-Tahar K; Cerundolo V; Banham AH; Hatton C; Blanchard T; Kusec R; Becker M; Smith GL; Pulford K
    Int J Cancer; 2006 Feb; 118(3):688-95. PubMed ID: 16114011
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unrelated donor stem cell transplantation after autologous transplantation: experience of a single center.
    Aschan J; Remberger M; Carlens S; Mattsson J; Dilber MS; Lönnqvist B; Björkstrand B
    Bone Marrow Transplant; 1999 Aug; 24(3):279-82. PubMed ID: 10455366
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Unrelated donor bone marrow transplantation for children with acute leukemia.
    Davies SM; Wagner JE; Shu XO; Blazar BR; Katsanis E; Orchard PJ; Kersey JH; Dusenbery KE; Weisdorf DJ; McGlave PB; Ramsay NK
    J Clin Oncol; 1997 Feb; 15(2):557-65. PubMed ID: 9053477
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Capping of leukemic cells with monoclonal anti-hla-a,B,C related to prognosis in childhood acute lymphoblastic leukemia.
    Hogeman PH; Veerman AJ; Huismans DR; van Zantwijk CH; Bezemer PD
    Acta Haematol; 1986; 76(2-3):119-23. PubMed ID: 3101348
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.